Literature DB >> 21833617

Serum adipokines and low density lipoprotein subfraction profile in hypopituitary patients with growth hormone deficiency.

Serpil Salman1, Ayse Kubat Uzum, Aysegul Telci, Faruk Alagol, Nese Colak Ozbey.   

Abstract

The aim was to evaluate the concentrations of lipid subfractions in relation to adipokines and metabolic parameters in adult growth hormone (GH)-deficient hypopituitary patients on conventional replacement therapy. The study included 21 GH deficient-hypopituitary patients (age: 36.0 ± 15.1 years, male/female: 7/14) on conventional replacement therapy other than GH and 20 comparable controls (age: 37.3 ± 14.0 years, male/female: 6/14). Lipid subfractions (Lipoprint system), serum adipokine (leptin, adiponectin, resistin) concentrations, body composition, a surrogate marker for insulin resistance (HOMA) and conventional lipid profile were evaluated. No statistically significant difference was found with respect to HOMA, adipokine concentrations and anthropometric parameters between patients and controls except for significantly increased waist-to-hip ratio in hypopituitary group. Total and LDL cholesterol concentrations were significantly higher in the patients. LDL particle size (268.88 ± 3.16 vs. 271.31 ± 3.11 Å, P = 0.151) and small-dense LDL subfraction did not differ significantly. According to logistic regression analysis, triglyceride concentrations ≥1.69 mmol/L was the sole parameter significantly and independently predicted small (<268 Å) LDL particle size (P = 0.019) in the whole group. Increased triglyceride concentrations affect LDL particle size in GH-deficient hypopituitary patients. Small dense LDL seems not directly contribute to atherogenic potential in hypopituitarism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21833617     DOI: 10.1007/s11102-011-0332-1

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  19 in total

1.  The metabolic syndrome--a new worldwide definition.

Authors:  K George M M Alberti; Paul Zimmet; Jonathan Shaw
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

Review 2.  Low-density lipoprotein size and cardiovascular risk assessment.

Authors:  M Rizzo; K Berneis
Journal:  QJM       Date:  2006-01

3.  Post-prandial alterations in LDL size and subclasses in patients with growth hormone deficiency.

Authors:  Manfredi Rizzo; Roman Trepp; Kaspar Berneis; Emanuel R Christ
Journal:  Growth Horm IGF Res       Date:  2007-12-03       Impact factor: 2.372

Review 4.  Adipokines and insulin resistance.

Authors:  Katja Rabe; Michael Lehrke; Klaus G Parhofer; Uli C Broedl
Journal:  Mol Med       Date:  2008-09-17       Impact factor: 6.354

Review 5.  Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee.

Authors:  P V Carroll; E R Christ; B A Bengtsson; L Carlsson; J S Christiansen; D Clemmons; R Hintz; K Ho; Z Laron; P Sizonenko; P H Sönksen; T Tanaka; M Thorne
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

6.  Increased leptin and tumour necrosis factor alpha per unit fat mass in hypopituitary women without growth hormone treatment.

Authors:  B Bülow; B Ahrén; E M Erfurth
Journal:  Eur J Endocrinol       Date:  2001-12       Impact factor: 6.664

7.  Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy.

Authors:  Manfredi Rizzo; Roman Trepp; Kaspar Berneis; Emanuel R Christ
Journal:  Eur J Endocrinol       Date:  2007-03       Impact factor: 6.664

8.  Effect of growth hormone (GH) on serum concentrations of leptin: study in patients with acromegaly and GH deficiency.

Authors:  M Miyakawa; T Tsushima; H Murakami; O Isozaki; H Demura; T Tanaka
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

9.  Premature mortality due to cardiovascular disease in hypopituitarism.

Authors:  T Rosén; B A Bengtsson
Journal:  Lancet       Date:  1990-08-04       Impact factor: 79.321

10.  Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults.

Authors:  Claudia Giavoli; Vincenzo Cappiello; Sabrina Corbetta; Cristina L Ronchi; Paola S Morpurgo; Emanuele Ferrante; Paolo Beck-Peccoz; Anna Spada
Journal:  Clin Endocrinol (Oxf)       Date:  2004-07       Impact factor: 3.478

View more
  3 in total

1.  Short-term efficacy of recombinant human GH therapy in cured acromegaly patients with GH deficiency: a single-center experience.

Authors:  Pinaki Dutta; Bhuvanesh Mahendran; K S Reddy; Jasmina Ahluwalia; Kim Vaiphei; R K Kochhar; Prakamya Gupta; Anand Srinivasan; Mahesh Prakash; Kanchan Kumar Mukherjee; V N Shah; Girish Parthan; Anil Bhansali
Journal:  Endocr Connect       Date:  2015-01-19       Impact factor: 3.335

Review 2.  A Functional Interplay between IGF-1 and Adiponectin.

Authors:  Stefania Orrù; Ersilia Nigro; Annalisa Mandola; Andreina Alfieri; Pasqualina Buono; Aurora Daniele; Annamaria Mancini; Esther Imperlini
Journal:  Int J Mol Sci       Date:  2017-10-14       Impact factor: 5.923

Review 3.  Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile.

Authors:  Balázs Ratku; Veronika Sebestyén; Annamária Erdei; Endre V Nagy; Zoltán Szabó; Sándor Somodi
Journal:  Pituitary       Date:  2022-02-01       Impact factor: 4.107

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.